表紙:エソテリック検査 (特殊検査) の世界市場 (2022年-2028年):市場予測 (検査タイプ・技術別)・地域的展望・成長の潜在性・市場シェア
市場調査レポート
商品コード
1064544

エソテリック検査 (特殊検査) の世界市場 (2022年-2028年):市場予測 (検査タイプ・技術別)・地域的展望・成長の潜在性・市場シェア

Esoteric Testing Market Size By Test Type, By Technology, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 130 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
エソテリック検査 (特殊検査) の世界市場 (2022年-2028年):市場予測 (検査タイプ・技術別)・地域的展望・成長の潜在性・市場シェア
出版日: 2022年03月04日
発行: Global Market Insights Inc.
ページ情報: 英文 130 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

エソテリック検査 (特殊検査) の市場は、世界の主要地域における消費者の製品需要の急増により、2028年にかけて堅調な成長が予測されています。

また、慢性疾患の発生率の上昇や、技術の最新開発により、予測期間中はさらなる成長が期待されています。

検査タイプ別で見ると、ゲノミクスの部門が2028年にかけて6.9%超のCAGRで大きく成長すると予測されています。NGSを含むシーケンシング技術の顕著な進歩や、遺伝性疾患の早期発見に関する意識の高まりが、今後数年の成長を刺激する可能性があります。また、技術別では、質量分析の部門が2021年に40億米ドル超の規模を示し、予測期間中の大きく成長すると予測されています。臨床検査に向けたR&D投資の増加、質量分析計の技術的躍進などが今後数年の発展を加速させる見通しです。

当レポートでは、世界のエソテリック検査 (特殊検査) の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、ビジネスモデル、市場規模の推移・予測、検査タイプ・技術・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 エソテリック検査 (特殊検査) 産業の考察

  • 産業の分類
  • 産業情勢
  • 産業への影響要因
    • 成長要因
    • 潜在的リスク&課題
  • 成長の可能性の分析
  • COVID-19:影響分析
  • ビジネスモデルの種類
  • 規制状況
  • ポーターの分析
  • 競合情勢
  • PESTEL分析

第4章 エソテリック検査 (特殊検査) 市場:検査タイプ別

  • 主要動向
  • 内分泌
  • 感染症・免疫
  • 腫瘍
  • 毒物
  • 神経
  • ゲノミクス
  • その他

第5章 エソテリック検査 (特殊検査) 市場:技術別

  • 主要動向
  • 質量分析
  • フローサイトメトリー
  • ELISA
  • ラジオイムノアッセイ
  • 化学発光
  • RT-PCR
  • その他

第6章 エソテリック検査 (特殊検査) 市場:地域別

  • 主要動向
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第7章 企業プロファイル

  • 競合ダッシュボード
  • ACM Global Laboratories
  • American Esoteric Laboratories(AEL)
  • Arup Laboratories
  • BioMONTR
  • Fulgent Genetics Inc
  • Genomic Health
  • Invitae
  • Laboratory Corporation of America
  • Mayo Medical Laboratories
  • Miraca Holdings Inc.
  • Myriad Genetics
  • Nordic Laboratories
  • OPKO Health Inc.
  • Quest Diagnostics, Inc.
図表

Data Tables

  • TABLE 1. Global esoteric testing market size, 2017 - 2021, (USD Million)
  • TABLE 2. Global esoteric testing market size, 2022 - 2028, (USD Million)
  • TABLE 3. Global esoteric testing market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 4. Global esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 5. Global esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 6. Global esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 7. Global esoteric testing market size, by region, 2017 - 2021 (USD Million)
  • TABLE 8. Global esoteric testing market size, by region, 2022 - 2028 (USD Million)
  • TABLE 9. Industry impact forces
  • TABLE 10. Endocrinology market size, by region, 2017 - 2021, (USD Million)
  • TABLE 11. Endocrinology market size, by region, 2022 - 2028, (USD Million)
  • TABLE 12. Infectious disease & immunology market size, by region, 2017 - 2021, (USD Million)
  • TABLE 13. Infectious disease & immunology market size, by region, 2022 - 2028, (USD Million)
  • TABLE 14. Oncology market size, by region, 2017 - 2021, (USD Million)
  • TABLE 15. Oncology market size, by region, 2022 - 2028, (USD Million)
  • TABLE 16. Toxicology market size, by region, 2017 - 2021, (USD Million)
  • TABLE 17. Toxicology market size, by region, 2022 - 2028, (USD Million)
  • TABLE 18. Neurology market size, by region, 2017 - 2021, (USD Million)
  • TABLE 19. Neurology market size, by region, 2022 - 2028, (USD Million)
  • TABLE 20. Genomics market size, by region, 2017 - 2021, (USD Million)
  • TABLE 21. Genomics market size, by region, 2022 - 2028, (USD Million)
  • TABLE 22. Others market size, by region, 2017 - 2021, (USD Million)
  • TABLE 23. Others market size, by region, 2022 - 2028, (USD Million)
  • TABLE 24. Mass spectrometry market size, by region, 2017 - 2021, (USD Million)
  • TABLE 25. Mass spectrometry market size, by region, 2022 - 2028, (USD Million)
  • TABLE 26. Flow cytometry market size, by region, 2017 - 2021, (USD Million)
  • TABLE 27. Flow cytometry market size, by region, 2022 - 2028, (USD Million)
  • TABLE 28. ELISA market size, by region, 2017 - 2021, (USD Million)
  • TABLE 29. ELISA market size, by region, 2022 - 2028, (USD Million)
  • TABLE 30. Radioimmunoassay market size, by region, 2017 - 2021, (USD Million)
  • TABLE 31. Radioimmunoassay market size, by region, 2022 - 2028, (USD Million)
  • TABLE 32. Chemiluminescence market size, by region, 2017 - 2021, (USD Million)
  • TABLE 33. Chemiluminescence market size, by region, 2022 - 2028, (USD Million)
  • TABLE 34. RT-PCR market size, by region, 2017 - 2021, (USD Million)
  • TABLE 35. RT-PCR market size, by region, 2022 - 2028, (USD Million)
  • TABLE 36. Others market size, by region, 2017 - 2021, (USD Million)
  • TABLE 37. Others market size, by region, 2022 - 2028, (USD Million)
  • TABLE 38. North America esoteric testing market size, by country, 2017 - 2021 (USD Million)
  • TABLE 39. North America esoteric testing market size, by country, 2022 - 2028 (USD Million)
  • TABLE 40. North America esoteric testing s market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 41. North America esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 42. North America esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 43. North America esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 44. U.S. esoteric testing market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 45. U.S. esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 46. U.S. esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 47. U.S. esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 48. Canada esoteric testing market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 49. Canada esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 50. Canada esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 51. Canada esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 52. Europe esoteric testing market size, by country, 2017 - 2021 (USD Million)
  • TABLE 53. Europe esoteric testing market size, by country, 2022 - 2028 (USD Million)
  • TABLE 54. Europe esoteric testing s market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 55. Europe esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 56. Europe esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 57. Europe esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 58. UK esoteric testing market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 59. UK esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 60. UK esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 61. UK esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 62. Germany esoteric testing market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 63. Germany esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 64. Germany esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 65. Germany esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 66. France esoteric testing market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 67. France esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 68. France esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 69. France esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 70. Italy esoteric testing market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 71. Italy esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 72. Italy esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 73. Italy esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 74. Spain esoteric testing market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 75. Spain esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 76. Spain esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 77. Spain esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 78. Asia Pacific esoteric testing market size, by country, 2017 - 2021 (USD Million)
  • TABLE 79. Asia Pacific esoteric testing market size, by country, 2022 - 2028 (USD Million)
  • TABLE 80. Asia Pacific esoteric testing s market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 81. Asia Pacific esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 82. Asia Pacific esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 83. Asia Pacific esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 84. Japan esoteric testing market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 85. Japan esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 86. Japan esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 87. Japan esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 88. China esoteric testing market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 89. China esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 90. China esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 91. China esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 92. India esoteric testing market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 93. India esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 94. India esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 95. India esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 96. South Korea esoteric testing market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 97. South Korea esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 98. South Korea esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 99. South Korea esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 100. Latin America esoteric testing market size, by country, 2017 - 2021 (USD Million)
  • TABLE 101. Latin America esoteric testing market size, by country, 2022 - 2028 (USD Million)
  • TABLE 102. Latin America esoteric testing s market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 103. Latin America esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 104. Latin America esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 105. Latin America esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 106. Brazil esoteric testing market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 107. Brazil esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 108. Brazil esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 109. Brazil esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 110. Mexico esoteric testing market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 111. Mexico esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 112. Mexico esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 113. Mexico esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 114. MEA esoteric testing market size, by country, 2017 - 2021 (USD Million)
  • TABLE 115. MEA esoteric testing market size, by country, 2022 - 2028 (USD Million)
  • TABLE 116. MEA esoteric testing s market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 117. MEA esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 118. MEA esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 119. MEA esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 120. South Africa esoteric testing market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 121. South Africa esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 122. South Africa esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 123. South Africa esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 124. Saudi Arabia esoteric testing market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 125. Saudi Arabia esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 126. Saudi Arabia esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 127. Saudi Arabia esoteric testing market size, by technology, 2022 - 2028 (USD Million)
  • TABLE 128. UAE esoteric testing market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 129. UAE esoteric testing market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 130. UAE esoteric testing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 131. UAE esoteric testing market size, by technology, 2022 - 2028 (USD Million)

Charts & Figures

  • FIG. 1. Market estimation approach
  • FIG. 2. Data validation
  • FIG. 3. Global esoteric testing industry 360 degree synopsis, 2017 - 2028
  • FIG. 4. Industry segmentation
  • FIG. 5. Global esoteric testing market size, 2017 - 2028 (USD Million)
  • FIG. 6. Growth potential analysis, by test type
  • FIG. 7. Growth potential analysis, by technology
  • FIG. 8. Porter's analysis
  • FIG. 9. PESTEL analysis
  • FIG. 10. Key segment trends, by test type
  • FIG. 11. Key segment trends, by technology
  • FIG. 12. Key regional trends
  • FIG. 13. Competitive dashboard, 2021
目次
Product Code: 1922

The esoteric testing market is anticipated to showcase robust growth through 2028 primarily on account of surging product demand among consumers in key regions across the globe. Additionally, latest developments in the technology, along with rising incidences of chronic illnesses, are set to further bolster industry expansion over the forecast period.

Industry players have been implementing effective strategies to gain a competitive edge in the market, which has positively influenced business growth. For instance, in February 2021, Mayo Clinic Laboratories, the U.S.-based medical laboratory, inked a partnership agreement with SRL Diagnostics, an Indian diagnostics expert, with the objective of promoting research, co-hosting seminars, training, conferences, and symposia around esoteric tests.

To cite another instance, in June 2021, ARUP Laboratories, a national reference laboratory under Utah University and a non-profit enterprise specializing in esoteric assays, announced the opening of its new laboratory facility in Salt Lake City, Utah. The novel structure spans two buildings and is a first-of-its-kind facility that has been designed to improve efficiency and boost test turnaround times. As a result, growing presence of diagnostic laboratories in leading regions has played a vital role in the growth of the esoteric testing industry in recent years.

For comprehensive assessment, the esoteric testing market has been categorized on the basis of technology, test type, and region. Based on test type, the market has been segregated further into infectious disease & immunology, endocrinology, toxicology, oncology, genomics, neurology, and others.

The genomics sub-segment garnered a substantial valuation in 2021 and is slated to grow at more than 6.9% CAGR between 2022 and 2028. Notable advancements in the sequencing technologies, including NGS, and surging awareness regarding the early detection of genetic disorders are likely to stimulate segmental growth in the forthcoming years.

From the technology perspective, the esoteric testing market has been divided into flow cytometry, ELISA, mass spectrometry, chemiluminescence, RT-PCR, radioimmunoassay, and others. In 2021, the mass spectrometry sub-segment was valued at over USD 4.0 billion and is projected to observe sizable growth through the assessment period. Increasing R&D investments towards clinical testing, coupled with technological breakthroughs in mass spectrometers, is anticipated to accelerate segmental development in the coming years.

In the regional landscape, the Latin America esoteric testing market accounted for a significant portion of the overall industry revenue in 2021 and is estimated to attain a considerable revenue, growing at a CAGR of approximately 7.1% between 2022 and 2028. Increasing healthcare spending, rising awareness about rare and complex disorders, and prevalent expansion of specialty labs are poised to foster regional market outlook in the future.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates & working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 Middle East & Africa
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data Sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Esoteric testing industry 360 degree synopsis, 2017 - 2028
    • 2.1.1 Business trends
    • 2.1.2 Test type trends
    • 2.1.3 Technology trends
    • 2.1.4 Regional trends

Chapter 3 Esoteric Testing Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2028
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Technological advancements in esoteric testing
      • 3.3.1.2 Rising occurrence of complex and rare medical disorders in the U and Europe
      • 3.3.1.3 Increasing prevalence of cancer and infectious diseases in low and middle-income countries
      • 3.3.1.4 Growing demand for genomics and proteomics
      • 3.3.1.5 Rising awareness for early disease detection across the globe
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Dearth of qualified and trained professionals in developing countries
      • 3.3.2.2 Stringent regulatory framework
  • 3.4 Growth potential analysis
    • 3.4.1 By test type
    • 3.4.2 By technology
  • 3.5 COVID 19 impact analysis
  • 3.6 Types of business models
    • 3.6.1 Mobile lab services
    • 3.6.2 Full-service diagnostics
    • 3.6.3 Reference/ consulting Services
  • 3.7 Regulatory landscape
    • 3.7.1 U.S.
    • 3.7.2 Europe
    • 3.7.3 China
  • 3.8 Porter's analysis
  • 3.9 Competitive landscape, 2021
  • 3.10 PESTEL analysis

Chapter 4 Esoteric Testing Market, By Test Type

  • 4.1 Key segment trends
  • 4.2 Endocrinology
    • 4.2.1 Market estimates and forecast, by region, 2017 - 2028
  • 4.3 Infectious disease & immunology
    • 4.3.1 Market estimates and forecast, by region, 2017 - 2028
  • 4.4 Oncology
    • 4.4.1 Market estimates and forecast, by region, 2017 - 2028
  • 4.5 Toxicology
    • 4.5.1 Market estimates and forecast, by region, 2017 - 2028
  • 4.6 Neurology
    • 4.6.1 Market estimates and forecast, by region, 2017 - 2028
  • 4.7 Genomics
    • 4.7.1 Market estimates and forecast, by region, 2017 - 2028
  • 4.8 Others
    • 4.8.1 Market estimates and forecast, by region, 2017 - 2028

Chapter 5 Esoteric Testing Market, By Technology

  • 5.1 Key segment trends
  • 5.2 Mass spectrometry
    • 5.2.1 Market estimates and forecast, by region, 2017 - 2028
  • 5.3 Flow cytometry
    • 5.3.1 Market estimates and forecast, by region, 2017 - 2028
  • 5.4 ELISA
    • 5.4.1 Market estimates and forecast, by region, 2017 - 2028
  • 5.5 Radioimmunoassay
    • 5.5.1 Market estimates and forecast, by region, 2017 - 2028
  • 5.6 Chemiluminescence
    • 5.6.1 Market estimates and forecast, by region, 2017 - 2028
  • 5.7 RT-PCR
    • 5.7.1 Market estimates and forecast, by region, 2017 - 2028
  • 5.8 Others
    • 5.8.1 Market estimates and forecast, by region, 2017 - 2028

Chapter 6 Esoteric Testing Market, By Region

  • 6.1 Key regional trends
  • 6.2 North America
    • 6.2.1 Market estimates and forecast, by country, 2017 - 2028
    • 6.2.2 Market estimates and forecast, by test type, 2017 - 2028
    • 6.2.3 Market estimates and forecast, by technology, 2017 - 2028
    • 6.2.4 U.S.
      • 6.2.4.1 Market estimates and forecast, by test type, 2017 - 2028
      • 6.2.4.2 Market estimates and forecast, by technology, 2017 - 2028
    • 6.2.5 Canada
      • 6.2.5.1 Market estimates and forecast, by test type, 2017 - 2028
      • 6.2.5.2 Market estimates and forecast, by technology, 2017 - 2028
  • 6.3 Europe
    • 6.3.1 Market estimates and forecast, by country, 2017 - 2028
    • 6.3.2 Market estimates and forecast, by test type, 2017 - 2028
    • 6.3.3 Market estimates and forecast, by technology, 2017 - 2028
    • 6.3.4 UK
      • 6.3.4.1 Market estimates and forecast, by test type, 2017 - 2028
      • 6.3.4.2 Market estimates and forecast, by technology, 2017 - 2028
    • 6.3.5 Germany
      • 6.3.5.1 Market estimates and forecast, by test type, 2017 - 2028
      • 6.3.5.2 Market estimates and forecast, by technology, 2017 - 2028
    • 6.3.6 France
      • 6.3.6.1 Market estimates and forecast, by test type, 2017 - 2028
      • 6.3.6.2 Market estimates and forecast, by technology, 2017 - 2028
    • 6.3.7 Italy
      • 6.3.7.1 Market estimates and forecast, by test type, 2017 - 2028
      • 6.3.7.2 Market estimates and forecast, by technology, 2017 - 2028
    • 6.3.8 Spain
      • 6.3.8.1 Market estimates and forecast, by test type, 2017 - 2028
      • 6.3.8.2 Market estimates and forecast, by technology, 2017 - 2028
  • 6.4 Asia Pacific
    • 6.4.1 Market estimates and forecast, by country, 2017 - 2028
    • 6.4.2 Market estimates and forecast, by test type, 2017 - 2028
    • 6.4.3 Market estimates and forecast, by technology, 2017 - 2028
    • 6.4.4 Japan
      • 6.4.4.1 Market estimates and forecast, by test type, 2017 - 2028
      • 6.4.4.2 Market estimates and forecast, by technology, 2017 - 2028
    • 6.4.5 China
      • 6.4.5.1 Market estimates and forecast, by test type, 2017 - 2028
      • 6.4.5.2 Market estimates and forecast, by technology, 2017 - 2028
    • 6.4.6 India
      • 6.4.6.1 Market estimates and forecast, by test type e, 2017 - 2028
      • 6.4.6.2 Market estimates and forecast, by technology, 2017 - 2028
    • 6.4.7 South Korea
      • 6.4.7.1 Market estimates and forecast, by test type, 2017 - 2028
      • 6.4.7.2 Market estimates and forecast, by technology, 2017 - 2028
  • 6.5 Latin America
    • 6.5.1 Market estimates and forecast, by country, 2017 - 2028
    • 6.5.2 Market estimates and forecast, by test type, 2017 - 2028
    • 6.5.3 Market estimates and forecast, by technology, 2017 - 2028
    • 6.5.4 Brazil
      • 6.5.4.1 Market estimates and forecast, by test type, 2017 - 2028
      • 6.5.4.2 Market estimates and forecast, by technology, 2017 - 2028
    • 6.5.5 Mexico
      • 6.5.5.1 Market estimates and forecast, by test type, 2017 - 2028
      • 6.5.5.2 Market estimates and forecast, by technology, 2017 - 2028
  • 6.6 Middle East & Africa
    • 6.6.1 Market estimates and forecast, by country, 2017 - 2028
    • 6.6.2 Market estimates and forecast, by test type, 2017 - 2028
    • 6.6.3 Market estimates and forecast, by technology, 2017 - 2028
    • 6.6.4 South Africa
      • 6.6.4.1 Market estimates and forecast, by test type, 2017 - 2028
      • 6.6.4.2 Market estimates and forecast, by technology, 2017 - 2028
    • 6.6.5 Saudi Arabia
      • 6.6.5.1 Market estimates and forecast, by test type, 2017 - 2028
      • 6.6.5.2 Market estimates and forecast, by technology, 2017 - 2028
    • 6.6.6 UAE
      • 6.6.6.1 Market estimates and forecast, by test type, 2017 - 2028
      • 6.6.6.2 Market estimates and forecast, by technology, 2017 - 2028

Chapter 7 Company Profiles

  • 7.1 Competitive dashboard, 2021
  • 7.2 ACM Global Laboratories
    • 7.2.1 Business overview
    • 7.2.2 Financial data
    • 7.2.3 Product landscape
    • 7.2.4 Strategic outlook
    • 7.2.5 SWOT analysis
  • 7.3 American Esoteric Laboratories (AEL)
    • 7.3.1 Business overview
    • 7.3.2 Financial data
    • 7.3.3 Product landscape
    • 7.3.4 Strategic outlook
    • 7.3.5 SWOT analysis
  • 7.4 Arup Laboratories
    • 7.4.1 Business overview
    • 7.4.2 Financial data
    • 7.4.3 Product landscape
    • 7.4.4 Strategic outlook
    • 7.4.5 SWOT analysis
  • 7.5 BioMONTR
    • 7.5.1 Business overview
    • 7.5.2 Financial data
    • 7.5.3 Product landscape
    • 7.5.4 Strategic outlook
    • 7.5.5 SWOT analysis
  • 7.6 Fulgent Genetics Inc
    • 7.6.1 Business overview
    • 7.6.2 Financial data
    • 7.6.3 Product landscape
    • 7.6.4 Strategic outlook
    • 7.6.5 SWOT analysis
  • 7.7 Genomic Health
    • 7.7.1 Business overview
    • 7.7.2 Financial data
    • 7.7.3 Product landscape
    • 7.7.4 Strategic outlook
    • 7.7.5 SWOT analysis
  • 7.8 Invitae
    • 7.8.1 Business overview
    • 7.8.2 Financial data
    • 7.8.3 Product landscape
    • 7.8.4 Strategic outlook
    • 7.8.5 SWOT analysis
  • 7.9 Laboratory Corporation of America
    • 7.9.1 Business overview
    • 7.9.2 Financial data
    • 7.9.3 Product landscape
    • 7.9.4 Strategic outlook
    • 7.9.5 SWOT analysis
  • 7.10 Mayo Medical Laboratories
    • 7.10.1 Business overview
    • 7.10.2 Financial data
    • 7.10.3 Product landscape
    • 7.10.4 Strategic outlook
    • 7.10.5 SWOT analysis
  • 7.11 Miraca Holdings Inc.
    • 7.11.1 Business overview
    • 7.11.2 Financial data
    • 7.11.3 Product landscape
    • 7.11.4 Strategic outlook
    • 7.11.5 SWOT analysis
  • 7.12 Myriad Genetics
    • 7.12.1 Business overview
    • 7.12.2 Financial data
    • 7.12.3 Product landscape
    • 7.12.4 Strategic outlook
    • 7.12.5 SWOT analysis
  • 7.13 Nordic Laboratories
    • 7.13.1 Business overview
    • 7.13.2 Financial data
    • 7.13.3 Product landscape
    • 7.13.4 Strategic outlook
    • 7.13.5 SWOT analysis
  • 7.14 OPKO Health Inc.
    • 7.14.1 Business overview
    • 7.14.2 Financial data
    • 7.14.3 Product landscape
    • 7.14.4 Strategic outlook
    • 7.14.5 SWOT analysis
  • 7.15 Quest Diagnostics, Inc.
    • 7.15.1 Business overview
    • 7.15.2 Financial data
    • 7.15.3 Product landscape
    • 7.15.4 Strategic outlook
    • 7.15.5 SWOT analysis